OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Episode 34: The Future of the Life Sciences Executive
Lisa Henderson
Lisa Henderson is Editor-in-Chief of Applied Clinical Trials and Pharm Exec. She can be reached at lhenderson@mmhgroup.com.
Christen Harm
Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com
Pharmaceutical Executive
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Related Content:
Editorial Podcasts